A. Hellstern

Comparison of the ImmunoCyt test and urinary cytology with other urine tests in the detection and surveillance of bladder cancer

H. Huland, S. Hautmann, A. Erbersdobler, 2004, World Journal of Urology.

Are false-positive urine markers for the detection of bladder carcinoma really wrong or do they predict tumor recurrence?

H. Huland, M. Toma, P. Hammerer, 2003, European urology.

Comparison of multitarget fluorescence in situ hybridization in urine with other noninvasive tests for detecting bladder cancer

H. Huland, K. Pantel, D. Weisenberger, 2003, BJU international.

Comparative Evaluation of the Datex-Ohmeda S/5 Entropy Module and the Bispectral Index® Monitor during Propofol–Remifentanil Anesthesia

Thomas Standl, P. Bischoff, T. Standl, 2004, Anesthesiology.

Clinical use of urinary markers for the detection and prognosis of bladder carcinoma: a comparison of immunocytology with monoclonal antibodies against Lewis X and 486p3/12 with the BTA STAT and NMP22 tests.

M. Graefen, H. Huland, S. Hautmann, 2002, The Journal of urology.